AusPAR: Insulin degludec / Insulin aspart

Australian Public Assessment Report

AusPAR

AusPAR: Insulin degludec (rys)/insulin aspart (rys) [PDF, 887.79 KB]

AusPAR: Insulin degludec (rys)/insulin aspart (rys) [Word, 1.09 MB]

Attachment: Product Information: Insulin degludec (rys)/insulin aspart (rys) [PDF, 415.49 KB]

Attachment: Product Information: Insulin degludec (rys)/insulin aspart (rys) [Word, 344.52 KB]

Attachment: Extract from Clinical Evaluation Report: Insulin degludec (rys)/insulin aspart (rys) [PDF, 1020.26 KB]

Attachment: Extract from Clinical Evaluation Report: Insulin degludec (rys)/insulin aspart (rys) [Word, 2.06 MB]

Device/Product Name

Ryzodeg 70/30 FlexTouch; Ryzodeg 70/30 Penfill

Active ingredients

Insulin degludec / Insulin aspart

AusPAR Date

22 May 2018

Published

16 July 2018

Submission Number

PM-2016-02723-1-5

Submission Type

New chemical entity

Decision

Approved